Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-21-038385

Director acquired 2,074 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
NELSEN ROBERT Director 2021-06-02 Grant or award +2,074 12,432 D
Derivatives
NELSEN ROBERT Director 2021-06-02 Grant or award · Stock Option (right to buy) +6,222 6,222 D
Loading xslF345X03/doc4.xml…